Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
July 2017

Valbenazine (Ingrezza): The First Drug Approved to Treat TD
Valbenazine (Ingrezza), an inhibitor of vesicular monoamine transporter 2 (VMAT2), is the first medication approved by the FDA to treat tardive dyskinesia.

A Dietary Supplement to Reduce the Risk of Postpartum Depression?
In a small, open-label trial, a dietary supplement decreased the propensity for sadness in postpartum women.

Pimavanserin (Nuplazid) for Parkinson Disease Psychosis
Pimavanserin (Nuplazid), a new molecular entity, is the first drug approved by the FDA to treat Parkinson disease psychosis.

In Brief
Review Finds that Dietary Supplements and Special Diets Do Not Improve Autism Symptoms; Aerobic Exercise Improves Executive Function in Adults with Vascular Cognitive Impairment

Don't Forget Clozapine
A recent survey found that US residents are hesitant to prescribe clozapine (Clozaril and others) for patients with schizophrenia, citing fear of side effects and lack of sufficient training on how to properly prescribe and monitor clozapine treatment.

Biological Therapies in Psychiatry Newsletter written by Alan J. Gelenberg, MD
For 40 years,
BTP has been the source for up-to-date information on psychotropic medications and other biological treatments for mental disorders.

This year’s volume of Biological Therapies in Psychiatry, our 40th, will be our last. Our final issue will be December 2017. We will be in touch with anyone whose subscription extends beyond that date to arrange compensation. My special thanks to BTP’s spectacular staff for their decades of excellence and friendship, and my gratitude to you, our loyal readers.
— Alan J. Gelenberg, M.D.

Dr. Alan Gelenberg's Blog
Dr. Gelenberg’s thoughts on psychiatry today… and where it’s headed in the future.
BTP Gift Subscriptions
Order and receive 3 bonus issues added to your own subscription as our thanks.
Activate Free Online Access for Residents
Register now, or if you are completing your residency and received a promotional mailing, enter your code.

Subscribe to BTP
Subscribing to BTP is easy! You can receive the print version with online access, or online only.
CME Credit
Earn 12 Category 1 CME credits for answering questions based on material published in BTP throughout the year.

BTP Subscriber Quote
"With time as tight as it is, I really appreciate the sheer volume of material that you review and summarize for us. You provide a tremendous service to busy clinicians like me and those we serve. Thanks again!"

- J. Rutherford, M.D.